Veterinary Medicine Information website

Drontal Plus Flavour Tablets for Dogs

Authorised
  • Febantel
  • Praziquantel
  • Pyrantel embonate
Download as PDF

Product identification

Medicine name:
Drontal Plus Flavour Tablets for Dogs
Active substance:
  • Febantel
  • Praziquantel
  • Pyrantel embonate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Febantel
    150.00
    milligram(s)
    /
    1.00
    Tablet
  • Praziquantel
    50.00
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel embonate
    144.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AF30
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Container material: Polypropylene-coated aluminium foil.Container colour: White.Container sizes: Cartons containing 108 tablets.
  • Container material: Polypropylene-coated aluminium foil.Container colour: White.Container sizes: Cartons containing 102 tablets.
  • Container material: Polypropylene-coated aluminium foil.Container colour: White.Container sizes: Cartons containing 24 tablets.
  • Container material: Polypropylene-coated aluminium foil.Container colour: White.Container sizes: Cartons containing 6 tablets.
  • Container material: Polypropylene-coated aluminium foil.Container colour: White.Container sizes: Cartons containing 2 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Europeenne De Pharmacotechnie Europhartech
  • KVP Pharma+Veterinaer Produkte GmbH
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10521/011/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download